Primary Hyperparathyroidism - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Primary Hyperparathyroidism – Complete Medical Guide

Primary Hyperparathyroidism – A Comprehensive Patient Guide

Overview

Primary hyperparathyroidism (PHPT) is a disorder in which one or more of the parathyroid glands produce too much parathyroid hormone (PTH). Excess PTH raises calcium levels in the blood (hypercalcemia) and can lead to bone loss, kidney stones, and a range of other systemic effects.

  • Who it affects: Most commonly adults over 50 years old; women are affected about 3–4 times more often than men.
  • Prevalence: In the United States, PHPT is the third most common endocrine disorder after diabetes and thyroid disease, affecting roughly 1 %–2 % of the population (≈3 million people) and up to 4 % of post‑menopausal women.1
  • Typical course: Many patients are diagnosed incidentally on routine blood work because early disease often produces few symptoms.

Symptoms

Symptoms result from elevated calcium and the direct actions of PTH on bone, kidney, and gastrointestinal (GI) systems. Not all patients experience every symptom; some may be asymptomatic.

Classic “Bones, Stones, Groans & Moans”

  • Bone pain & fractures: PTH stimulates bone resorption, leading to osteoporosis, especially in the forearms, hips, and spine.
  • Kidney stones: Hypercalciuria (high calcium in urine) predisposes to calcium oxalate stones, causing flank pain, hematuria, and urinary urgency.
  • Groans (GI symptoms): Nausea, vomiting, loss of appetite, constipation, and abdominal pain.
  • Moans (Neuro‑psychiatric): Fatigue, depression, anxiety, memory difficulty, irritability, and in severe cases, psychosis.

Additional Manifestations

  • Excessive thirst and frequent urination (polyuria/polydipsia) – due to nephrogenic diabetes insipidus‑like effect of calcium.
  • Muscle weakness, especially in the proximal muscles.
  • Arthralgia (joint pain) and calcific tendinitis.
  • Fatigue and generalized malaise.
  • Elevated blood pressure – calcium can influence vascular tone.
  • Gout attacks – hypercalcemia can increase uric acid levels.

Causes and Risk Factors

PHPT is “primary” because the parathyroid gland abnormality is the source of excess hormone, not a secondary compensatory response.

Underlying Causes

  • Single adenoma (≈85 %): A benign tumor in one gland that autonomously secretes PTH.
  • Double adenomas or hyperplasia (≈10‑15 %): Enlargement of two or more glands.
  • Parathyroid carcinoma (≈1 %): Rare malignant tumor; usually presents with markedly high calcium (>14 mg/dL).

Risk Factors

  • Age >50 years.
  • Female sex (post‑menopausal women at highest risk).
  • Family history of hyperparathyroidism or related syndromes (e.g., Multiple Endocrine Neoplasia type 1 or MEN2A).
  • Radiation exposure to the head/neck.
  • Chronic lithium therapy – lithium can raise PTH set‑point.
  • Vitamin D deficiency – may mask hypercalcemia and delay diagnosis.

Diagnosis

Diagnosing PHPT relies on a combination of biochemical tests, imaging, and sometimes genetic evaluation.

Laboratory Evaluation

  • Serum calcium (total or ionized): Elevated in >90 % of cases; adjusted for albumin.
  • Parathyroid hormone (PTH): Inappropriately “normal” or high in the setting of hypercalcemia (i.e., fails to suppress).
  • 24‑hour urinary calcium: Helps differentiate PHPT from familial hypocalciuric hypercalcemia (FHH).
  • 25‑hydroxyvitamin D: Frequently low; supplementation is part of management.
  • Phosphate: Often low because PTH promotes renal phosphate wasting.
  • Creatinine & eGFR: Assess kidney function.

Imaging Studies

  • Neck ultrasound: First‑line, non‑invasive; can locate enlarged glands.
  • Sestamibi (Tc‑99m) scan: Functional imaging that highlights hyper‑functioning tissue; often combined with CT (SPECT‑CT) for precise localization before surgery.
  • Dual‑energy X‑ray absorptiometry (DEXA): Evaluates bone mineral density (BMD); osteoporosis is present in ~30‑50 % of untreated patients.2
  • Kidney imaging (ultrasound or CT): Detects stones or nephrocalcinosis.

Genetic Testing (Selective)

Patients with a strong family history or features of MEN syndromes may undergo testing for MEN1, CDC73, or CASR gene mutations.

Treatment Options

Management is individualized based on severity, age, symptom burden, and surgical risk.

When Surgery Is Indicated

Parathyroidectomy (removal of the over‑active gland(s)) is the definitive cure and is recommended for:

  • Serum calcium >1 mg/dL above the upper limit of normal.
  • Age <50 years (even if asymptomatic).
  • Bone density T‑score ≤ ‑2.5 at the lumbar spine, hip, or distal radius.
  • History of kidney stones or renal impairment.
  • Markedly elevated PTH (>2‑3 × upper limit).
  • Progressive disease on serial monitoring.

Surgical Techniques

  • Focused minimally invasive parathyroidectomy (MIP): Uses pre‑operative localization to remove a single adenoma through a small incision.
  • Bilateral neck exploration: Traditional approach when multiple glands are involved.
  • Intra‑operative PTH monitoring ensures complete removal (PTH should drop >50 % within 10 minutes).

Medical Management (When Surgery Is Not Immediate)

  • Hydration: Adequate fluid intake (≥2‑3 L/day) reduces calcium levels and stone risk.
  • Bisphosphonates (e.g., alendronate): Inhibit bone resorption, improve BMD, and modestly lower calcium.
  • Calcimimetics (cinacalcet): Increases the sensitivity of the calcium‑sensing receptor, lowering PTH and serum calcium; useful in patients who cannot undergo surgery.
  • Vitamin D repletion: Correct deficiency (typically 800–2000 IU cholecalciferol daily) after calcium is controlled to avoid worsening hypercalcemia.
  • Thiazide diuretics: Generally avoided because they increase calcium reabsorption; however, low‑dose thiazides may be used cautiously if hypertension requires treatment.
  • Monitoring: Serum calcium, PTH, renal function, and BMD every 6–12 months.

Lifestyle Adjustments

  • Limit calcium‑rich supplements >1 g/day.
  • Maintain moderate physical activity to support bone health.
  • Stay well‑hydrated; aim for urine output >2 L/day.
  • Avoid excessive sodium and protein, which increase calcium excretion.

Living with Primary Hyperparathyroidism

Even after successful treatment, ongoing self‑care helps maintain optimal health.

Daily Management Tips

  • Hydration: Carry a water bottle; sip regularly.
  • Nutrition: Emphasize leafy greens, berries, and fortified plant milks while moderating high‑calcium foods (e.g., fortified orange juice, cheese) if calcium remains high.
  • Bone health: Ensure adequate intake of vitamin D (800–1000 IU) and calcium (1000 mg/day from diet, unless your physician advises otherwise). Include weight‑bearing exercises (walking, brisk walking, resistance training) ≥3×/week.
  • Kidney stone prevention: Reduce oxalate‑rich foods (spinach, nuts, chocolate) if you have a stone history, and keep urine calcium low with proper hydration.
  • Medication adherence: Take bisphosphonates with a full glass of water, remain upright for 30 minutes, and avoid eating for 30 minutes after dosing.
  • Follow‑up schedule: After surgery, obtain calcium and PTH labs at 1 month, 6 months, then annually. If medically managed, labs every 3–6 months initially.
  • Support network: Join patient groups (e.g., Hyperparathyroidism Association) for shared experiences and updates on research.

Prevention

Because most cases are sporadic and not preventable, primary prevention focuses on early detection and mitigation of modifiable risk factors.

  • Routine calcium screening for at‑risk groups (post‑menopausal women, patients on lithium, or those with a family history).
  • Maintain adequate vitamin D levels; deficiency may mask early hyperparathyroidism.
  • Limit chronic lithium exposure when possible; discuss alternatives with your psychiatrist.
  • Adopt a balanced diet and stay active to preserve bone density, potentially reducing the impact of undiagnosed PHPT.

Complications

If left untreated, persistent hypercalcemia can lead to serious, sometimes irreversible problems.

  • Osteoporosis & fragility fractures: Up to 50 % of untreated patients develop decreased BMD.
  • Nephrolithiasis & chronic kidney disease: Recurrent stones can cause renal scarring; hypercalcemia itself is nephrotoxic.
  • Cardiovascular disease: Hypercalcemia is associated with hypertension, left‑ventricular hypertrophy, and increased arterial stiffness.
  • Neuro‑cognitive decline: Chronic high calcium may impair memory and mood.
  • Pancreatitis: Rare but documented; hypercalcemia can precipitate pancreatic inflammation.
  • Parathyroid carcinoma: Though rare, untreated hyperparathyroidism may mask an underlying malignancy; sudden rise in calcium >14 mg/dL warrants thorough evaluation.

When to Seek Emergency Care

Warning signs that require immediate medical attention:
  • Severe abdominal pain, vomiting, or constipation that does not improve.
  • Sudden onset of intense back or flank pain suggestive of a kidney stone.
  • Confusion, disorientation, lethargy, or new‑onset seizures.
  • Rapid heart rhythm (palpitations) or loss of consciousness.
  • Muscle weakness making it difficult to stand or walk.
Call 911 or go to the nearest emergency department if any of these occur.

References

  1. Mayo Clinic. Primary hyperparathyroidism. https://www.mayoclinic.org/diseases-conditions/primary-hyperparathyroidism/symptoms-causes/syc-20356169
  2. Cleveland Clinic. Primary Hyperparathyroidism. https://my.clevelandclinic.org/health/diseases/17230-primary-hyperparathyroidism
  3. NIH Office of Dietary Supplements. Calcium. https://ods.od.nih.gov/factsheets/Calcium-Consumer/
  4. American Thyroid Association. Guidelines for the Treatment of Primary Hyperparathyroidism. 2022. https://www.thyroid.org/primary-hyperparathyroidism-guidelines
  5. World Health Organization. WHO classification of tumours of endocrine organs (2023). https://www.who.int/publications/i/item/9789240016899
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References